Skip to main content

Advertisement

SpringerLink
Log in

The role of Fas/FasL in immunosuppression induced by human tumors

  • REVIEW
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Pathology, University of Pittsburgh School of Medicine, and the University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA, , , , , , US

    Theresa L. Whiteside

  2. Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA, , , , , , US

    Hannah Rabinowich

Authors
  1. Theresa L. Whiteside
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hannah Rabinowich
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 1 December 1997 / Accepted: 22 January 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whiteside, T., Rabinowich, H. The role of Fas/FasL in immunosuppression induced by human tumors. Cancer Immunol Immunother 46, 175–184 (1998). https://doi.org/10.1007/s002620050476

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002620050476

Keywords

Search

Navigation